223 related articles for article (PubMed ID: 30635228)
1. The effect of electroconvulsive therapy on cerebral monoamine oxidase A expression in treatment-resistant depression investigated using positron emission tomography.
Baldinger-Melich P; Gryglewski G; Philippe C; James GM; Vraka C; Silberbauer L; Balber T; Vanicek T; Pichler V; Unterholzner J; Kranz GS; Hahn A; Winkler D; Mitterhauser M; Wadsak W; Hacker M; Kasper S; Frey R; Lanzenberger R
Brain Stimul; 2019; 12(3):714-723. PubMed ID: 30635228
[TBL] [Abstract][Full Text] [Related]
2. Monoamine oxidase A inhibitor occupancy during treatment of major depressive episodes with moclobemide or St. John's wort: an [11C]-harmine PET study.
Sacher J; Houle S; Parkes J; Rusjan P; Sagrati S; Wilson AA; Meyer JH
J Psychiatry Neurosci; 2011 Nov; 36(6):375-82. PubMed ID: 21463543
[TBL] [Abstract][Full Text] [Related]
3. Brain monoamine oxidase A in seasonal affective disorder and treatment with bright light therapy.
Spies M; James GM; Vraka C; Philippe C; Hienert M; Gryglewski G; Komorowski A; Kautzky A; Silberbauer L; Pichler V; Kranz GS; Nics L; Balber T; Baldinger-Melich P; Vanicek T; Spurny B; Winkler-Pjrek E; Wadsak W; Mitterhauser M; Hacker M; Kasper S; Lanzenberger R; Winkler D
Transl Psychiatry; 2018 Sep; 8(1):198. PubMed ID: 30242221
[TBL] [Abstract][Full Text] [Related]
4. High-dose testosterone treatment reduces monoamine oxidase A levels in the human brain: A preliminary report.
Kranz GS; Spies M; Vraka C; Kaufmann U; Klebermass EM; Handschuh PA; Ozenil M; Murgaš M; Pichler V; Rischka L; Nics L; Konadu ME; Ibeschitz H; Traub-Weidinger T; Wadsak W; Hahn A; Hacker M; Lanzenberger R
Psychoneuroendocrinology; 2021 Nov; 133():105381. PubMed ID: 34416504
[TBL] [Abstract][Full Text] [Related]
5. Nonconvulsive Electrotherapy for Treatment Resistant Unipolar and Bipolar Major Depressive Disorder: A Proof-of-concept Trial.
Regenold WT; Noorani RJ; Piez D; Patel P
Brain Stimul; 2015; 8(5):855-61. PubMed ID: 26187603
[TBL] [Abstract][Full Text] [Related]
6. Brain monoamine oxidase A binding in major depressive disorder: relationship to selective serotonin reuptake inhibitor treatment, recovery, and recurrence.
Meyer JH; Wilson AA; Sagrati S; Miler L; Rusjan P; Bloomfield PM; Clark M; Sacher J; Voineskos AN; Houle S
Arch Gen Psychiatry; 2009 Dec; 66(12):1304-12. PubMed ID: 19996035
[TBL] [Abstract][Full Text] [Related]
7. Elevated Monoamine Oxidase-A Distribution Volume in Borderline Personality Disorder Is Associated With Severity Across Mood Symptoms, Suicidality, and Cognition.
Kolla NJ; Chiuccariello L; Wilson AA; Houle S; Links P; Bagby RM; McMain S; Kellow C; Patel J; Rekkas PV; Pasricha S; Meyer JH
Biol Psychiatry; 2016 Jan; 79(2):117-26. PubMed ID: 25698585
[TBL] [Abstract][Full Text] [Related]
8. ELEctroconvulsive therapy (ECT) vs. Ketamine in patients with Treatment-resistant Depression: The ELEKT-D study protocol.
Mathew SJ; Wilkinson ST; Altinay M; Asghar-Ali A; Chang LC; Collins KA; Dale RM; Hu B; Krishnan K; Kellner CH; Malone DA; Murrough JW; Ostroff RB; Sanacora G; Shao M; Anand A
Contemp Clin Trials; 2019 Feb; 77():19-26. PubMed ID: 30572160
[TBL] [Abstract][Full Text] [Related]
9. Global decrease of serotonin-1A receptor binding after electroconvulsive therapy in major depression measured by PET.
Lanzenberger R; Baldinger P; Hahn A; Ungersboeck J; Mitterhauser M; Winkler D; Micskei Z; Stein P; Karanikas G; Wadsak W; Kasper S; Frey R
Mol Psychiatry; 2013 Jan; 18(1):93-100. PubMed ID: 22751491
[TBL] [Abstract][Full Text] [Related]
10. Greater monoamine oxidase a binding in perimenopausal age as measured with carbon 11-labeled harmine positron emission tomography.
Rekkas PV; Wilson AA; Lee VW; Yogalingam P; Sacher J; Rusjan P; Houle S; Stewart DE; Kolla NJ; Kish S; Chiuccariello L; Meyer JH
JAMA Psychiatry; 2014 Aug; 71(8):873-9. PubMed ID: 24898155
[TBL] [Abstract][Full Text] [Related]
11. Monoamine Oxidase B Total Distribution Volume in the Prefrontal Cortex of Major Depressive Disorder: An [11C]SL25.1188 Positron Emission Tomography Study.
Moriguchi S; Wilson AA; Miler L; Rusjan PM; Vasdev N; Kish SJ; Rajkowska G; Wang J; Bagby M; Mizrahi R; Varughese B; Houle S; Meyer JH
JAMA Psychiatry; 2019 Jun; 76(6):634-641. PubMed ID: 30840042
[TBL] [Abstract][Full Text] [Related]
12. Confirmatory Efficacy and Safety Trial of Magnetic Seizure Therapy for Depression (CREST-MST): study protocol for a randomized non-inferiority trial of magnetic seizure therapy versus electroconvulsive therapy.
Daskalakis ZJ; Tamminga C; Throop A; Palmer L; Dimitrova J; Farzan F; Thorpe KE; McClintock SM; Blumberger DM
Trials; 2021 Nov; 22(1):786. PubMed ID: 34749782
[TBL] [Abstract][Full Text] [Related]
13. The impact of treatment resistance on outcome and course of electroconvulsive therapy in major depressive disorder.
Rovers JJE; Vissers P; Loef D; van Waarde JA; Verdijk JPAJ; Broekman BFP; Vergouwen ACM; Oudega ML; van Exel E; Coenen R; Everaerd DS; Tendolkar I; Dols A; van Eijndhoven PFP
Acta Psychiatr Scand; 2023 Jun; 147(6):570-580. PubMed ID: 37020420
[TBL] [Abstract][Full Text] [Related]
14. Episodic memory following deep brain stimulation of the ventral anterior limb of the internal capsule and electroconvulsive therapy.
Bergfeld IO; Mantione M; Hoogendoorn MLC; Horst F; Notten P; Schuurman PR; Denys D
Brain Stimul; 2017; 10(5):959-966. PubMed ID: 28754306
[TBL] [Abstract][Full Text] [Related]
15. Serum BDNF as a peripheral biomarker of treatment-resistant depression and the rapid antidepressant response: A comparison of ketamine and ECT.
Allen AP; Naughton M; Dowling J; Walsh A; Ismail F; Shorten G; Scott L; McLoughlin DM; Cryan JF; Dinan TG; Clarke G
J Affect Disord; 2015 Nov; 186():306-11. PubMed ID: 26275358
[TBL] [Abstract][Full Text] [Related]
16. Antidepressant Effects of Electroconvulsive Therapy Unrelated to the Brain's Functional Network Connectivity alterations at an Individual Level.
Chen GD; Ji F; Li GY; Lyu BX; Hu W; Zhuo CJ
Chin Med J (Engl); 2017 Feb; 130(4):414-419. PubMed ID: 28218214
[TBL] [Abstract][Full Text] [Related]
17. Elevated monoamine oxidase a levels in the brain: an explanation for the monoamine imbalance of major depression.
Meyer JH; Ginovart N; Boovariwala A; Sagrati S; Hussey D; Garcia A; Young T; Praschak-Rieder N; Wilson AA; Houle S
Arch Gen Psychiatry; 2006 Nov; 63(11):1209-16. PubMed ID: 17088501
[TBL] [Abstract][Full Text] [Related]
18. Lower Monoamine Oxidase-A Total Distribution Volume in Impulsive and Violent Male Offenders with Antisocial Personality Disorder and High Psychopathic Traits: An [(11)C] Harmine Positron Emission Tomography Study.
Kolla NJ; Matthews B; Wilson AA; Houle S; Bagby RM; Links P; Simpson AI; Hussain A; Meyer JH
Neuropsychopharmacology; 2015 Oct; 40(11):2596-603. PubMed ID: 26081301
[TBL] [Abstract][Full Text] [Related]
19. Effect of MAOA DNA Methylation on Human in Vivo Protein Expression Measured by [11C]harmine Positron Emission Tomography.
Handschuh PA; Murgaš M; Vraka C; Nics L; Hartmann AM; Winkler-Pjrek E; Baldinger-Melich P; Wadsak W; Winkler D; Hacker M; Rujescu D; Domschke K; Lanzenberger R; Spies M
Int J Neuropsychopharmacol; 2023 Feb; 26(2):116-124. PubMed ID: 36573644
[TBL] [Abstract][Full Text] [Related]
20. Impact of genetic variants within serotonin turnover enzymes on human cerebral monoamine oxidase A in vivo.
Spies M; Murgaš M; Vraka C; Philippe C; Gryglewski G; Nics L; Balber T; Baldinger-Melich P; Hartmann AM; Rujescu D; Hacker M; Winkler-Pjrek E; Winkler D; Lanzenberger R
Transl Psychiatry; 2023 Jun; 13(1):208. PubMed ID: 37322010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
